Composition: Griseofulvin IP 125 mg / 250 mg / 500 mg; Griseofulvin BP 125 mg (GRIDORN-125).
Dosage Form: Uncoated tablets
Usage: Treatment of susceptible dermatophyte infections including ringworm, athlete's foot and jock itch when oral therapy is indicated.
Category: Antifungal Drugs
Therapeutic Category: Antifungal
SKU: Griseofulvin Tablets
Categories: Pharmaceutical Exporter India, Pharmaceutical Formulations India, WHO GMP Certified Formulations
Griseofulvin Tablets is listed in our pharmaceutical product portfolio for business-to-business enquiries. Product-specific formulation details, available strengths, dosage form, pack configuration and supply terms should be confirmed against the current product specification before ordering.
For distributor, wholesaler, hospital procurement and export enquiries, please request the applicable product specifications, batch documentation, shelf-life information, packaging options and regulatory documents. Availability and documentation depend on the product and destination market.
Manufactured by: Healthy Life Pharma Pvt. Ltd. (WHO-GMP Certified)
Exported by: Healthy Inc (Star Export House)
Healthy Life Pharma Pvt. Ltd. manufactures Griseofulvin Tablets in India. Griseofulvin is an oral antifungal medicine used for susceptible dermatophyte infections of the scalp, skin, hair and nails when systemic treatment is appropriate. It is not effective for all fungal infections and is not a treatment for Candida infections.
Healthy Inc handles export enquiries and international supply coordination, subject to product registration and market requirements.
| Product / Brand | Composition per tablet | Dosage form |
|---|---|---|
| Griseofulvin Tablets IP 125 mg | Griseofulvin IP 125 mg; excipients q.s. | Uncoated |
| GRIDORN-125 (IP) | Griseofulvin IP 125 mg | Uncoated |
| Griseofulvin Tablets IP 250 mg | Griseofulvin IP 250 mg; excipients q.s. | Uncoated |
| Griseofulvin Tablets IP 500 mg | Griseofulvin IP 500 mg | Uncoated |
| GRIDORN-125 (BP) | Griseofulvin BP 125 mg | Uncoated |
Generic name: Griseofulvin Tablets IP / BP (as specified per variant). CAS: 126-07-8. Available strengths in supplied compositions: 125 mg, 250 mg and 500 mg. Therapeutic class: Systemic antifungal. Category: Antifungal Drugs. Packaging and shelf life: To be confirmed against the approved pack and stability data.
Griseofulvin has low water solubility; particle-size control and formulation design can affect dissolution and absorption. Micronized and ultramicronized formulations may differ in bioavailability and are not automatically dose-interchangeable. The particle-size specification and manufacturing process of these supplied IP/BP tablets must be verified against the actual product dossier rather than assumed.
Product-specific controls include identification, assay, impurities, content uniformity, dissolution, stability and packaging integrity, as required by the applicable approved specification. Particle-size distribution may be relevant where a micronized formulation is claimed. Exact dissolution and assay limits are those in the relevant pharmacopoeial monograph or registered specification.
Griseofulvin inhibits fungal cell division by interfering with microtubule function and concentrates in newly formed keratin. It may be used for tinea capitis and selected infections such as tinea corporis, cruris or pedis when oral treatment is indicated. The organism, infection site and alternatives influence the choice of treatment; some nail infections are better treated with other agents.
For international B2B enquiries, product-specific certificates of analysis, available manufacturing certificates, registration documents and export logistics can be discussed. Availability of CTD/ACTD dossiers, COPP, free sale certificates and destination-market approval should be confirmed before commitment.
Q: Who manufactures Griseofulvin Tablets?
A: Healthy Life Pharma Pvt. Ltd., India, as supplied in the product details.
Q: What strengths are listed?
A: Griseofulvin 125 mg, 250 mg and 500 mg, including GRIDORN-125 IP and BP versions.
Q: Should it be taken with food?
A: Food, particularly a fatty meal, can increase absorption of some griseofulvin formulations; follow the product label and prescriber instructions.
Q: How long is treatment?
A: Duration depends on the infection site, causative organism, formulation and response; scalp and nail infections often need longer treatment than skin infections.
Dosage must be prescribed according to age, body weight, infection, renal/hepatic considerations and whether the product is micronized or ultramicronized. Do not apply a single adult or paediatric regimen to every formulation. Complete the prescribed course and follow the approved instructions for administration with meals.
Store in a dry place, protected from excess heat and moisture, according to the approved product label. Keep the container tightly closed and out of reach of children.